AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · IEX Real-Time Price · USD
0.360
-0.013 (-3.56%)
Jul 2, 2024, 4:00 PM EDT - Market closed
AIM ImmunoTech Revenue
AIM ImmunoTech had revenue of $193.00K in the twelve months ending March 31, 2024, with 23.72% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $40.00K, a -18.37% decrease year-over-year. In the year 2023, AIM ImmunoTech had annual revenue of $202.00K with 43.26% growth.
Revenue (ttm)
$193.00K
Revenue Growth
+23.72%
P/S Ratio
106.69
Revenue / Employee
$7,423
Employees
26
Market Cap
20.59M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 202.00K | 61.00K | 43.26% |
Dec 31, 2022 | 141.00K | 6.00K | 4.44% |
Dec 31, 2021 | 135.00K | -28.00K | -17.18% |
Dec 31, 2020 | 163.00K | 23.00K | 16.43% |
Dec 31, 2019 | 140.00K | -227.00K | -61.85% |
Dec 31, 2018 | 367.00K | -70.00K | -16.02% |
Dec 31, 2017 | 437.00K | 345.00K | 375.00% |
Dec 31, 2016 | 92.00K | -41.00K | -30.83% |
Dec 31, 2015 | 133.00K | -64.00K | -32.49% |
Dec 31, 2014 | 197.00K | 47.00K | 31.33% |
Dec 31, 2013 | 150.00K | -63.00K | -29.58% |
Dec 31, 2012 | 213.00K | 52.00K | 32.30% |
Dec 31, 2011 | 161.00K | 26.00K | 19.26% |
Dec 31, 2010 | 135.00K | 24.00K | 21.62% |
Dec 31, 2009 | 111.00K | -154.00K | -58.11% |
Dec 31, 2008 | 265.00K | -794.00K | -74.98% |
Dec 31, 2007 | 1.06M | 126.00K | 13.50% |
Dec 31, 2006 | 933.00K | -150.00K | -13.85% |
Dec 31, 2005 | 1.08M | -146.00K | -11.88% |
Dec 31, 2004 | 1.23M | 572.00K | 87.06% |
Dec 31, 2003 | 657.00K | -247.00K | -27.32% |
Dec 31, 2002 | 904.00K | 514.00K | 131.79% |
Dec 31, 2001 | 390.00K | -398.00K | -50.51% |
Dec 31, 2000 | 788.00K | 110.00K | 16.22% |
Dec 31, 1999 | 678.00K | 277.00K | 69.08% |
Dec 31, 1998 | 401.00K | 142.29K | 55.00% |
Dec 31, 1997 | 258.72K | 226.67K | 707.37% |
Dec 31, 1996 | 32.04K | -2.93M | -98.92% |
Dec 31, 1995 | 2.97M | 2.79M | 1,587.50% |
Dec 31, 1994 | 175.76K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cumberland Pharmaceuticals | 38.83M |
American Shared Hospital Services | 21.62M |
VBI Vaccines | 9.41M |
Singular Genomics Systems | 2.49M |
TherapeuticsMD | 1.20M |
Oncternal Therapeutics | 1.15M |
Aptorum Group | 431.38K |
AIM News
- 22 days ago - AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference - GlobeNewsWire
- 4 weeks ago - AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire
- 4 weeks ago - AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 6 weeks ago - AIM ImmunoTech to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer - GlobeNewsWire